Skip to main content
Fig. 2 | BMC Veterinary Research

Fig. 2

From: Pharmacokinetic/pharmacodynamic evaluation of gamithromycin against rabbit pasteurellosis

Fig. 2

In vitro PAE and PA-SME values for gamithromycin against P. multocidaCVCC 434. (A) Standard curve constructed by regression of the viable bacterial counts and absorbance (OD600nm) of P. multocida CVCC 434. The solid points represent the observed data and the line represents the best fitting curves as follows: y = 1.0633 ln(x) + 10.929 (R2 = 0.9453). (B-C) The PAEs (B) were measured after initial exposure to gamithromycin at 1× and 4× MIC against P. multocida CVCC 434; The PA-SME (C) was determined after an initial exposure to gamithromycin at 4×MIC. The horizontal bars represent the time required for viable counts of bacteria to increase by 1.0 log10 cfu/mL in the drug removal (PAE) and sub-MIC phase (PA-SME)

Back to article page